Pretty rare to see something like this, effectively doubled their market opportunity and maybe on the radar for a takeover by a Chinese pharma.
this is fairly exciting imo
Ann: Dimerix confirms Phase 3 study design appropriate for China, page-2
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $186.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 33.5¢ | $1.141M | 3.324M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 280031 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 455581 | 9 |
View Market Depth
| Last trade - 15.39pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.0¢ |
Change
-0.005 ( 1.45 %) |
||||
| Open | High | Low | Volume | ||
| 35.0¢ | 35.5¢ | 33.5¢ | 1411198 | ||
| Last updated 15.57pm 22/05/2024 ? | |||||
| DXB (ASX) Chart |